 MD News | Early PET Predicts Survival Outcomes in B-Cell Lymphoma Doctors Lounge An interim [ 18 F] fluorodeoxyglucose positron emission tomography can effectively predict the survival outcomes of patients with diffuse large B-cell lymphoma after two cycles of anthracycline-based chemotherapy plus rituximab, according to a study ... BiovaxID(R) Lymphoma Vaccine-Induced T-Cell Immune Responses Complement ... |
